Dizal Completes Enrollment for its Phase III Pivotal Study of Sunvozertinib vs. Platinum Doublet in Treatment Naïve NSCLC Patients with EGFR Exon20 Insertional Mutations
SHANGHAI, June 19, 2025 /PRNewswire/ -- Dizal announced the completion of patient enrollment for its WU-KONG28 clinical trial: a multinational, randomized phase III study evaluating the efficacy and safety of sunvozertinib versus platinum-based...
Rockefeller Foundation and The Bridgespan Group Collaborate to Catalyze High-Impact Philanthropy across Asia
New USD $100,000 grant supports the Bridgespan-led Funders Council's efforts to help scale philanthropic resources to tackle development challenges and spur economic opportunity BANGKOK, June 19, 2025 /PRNewswire/ -- The Rockefeller Foundation...
Fractal Named a Leader in Customer Analytics by Independent Research Firm
The report notes that Enterprises looking for top-of-the-line personalization and AI-powered next best experience should consider Fractal. NEW YORK, June 18, 2025 /PRNewswire/ -- Fractal (www.fractal.ai), a global provider of enterprise AI solutions...
Clover Initiates Phase I Clinical Trial for RSV + hMPV ± PIV3 Respiratory Combination Vaccine Candidates
-- Potential First-in-Class Respiratory Combination Vaccine Candidates SCB-1022 (RSV + hMPV) and SCB-1033 (RSV + hMPV + PIV3) Enter the Clinical Trial Stage -- SHANGHAI, June 17, 2025 /PRNewswire/ -- Clover Biopharmaceuticals, Ltd. (Clover; HKEX:...
POWERCHINA's CEME1 Project in Chile Advances Clean Energy and Land Resilience, Echoing the Spirit of the World Day to Combat Desertification and Drought
BEIJING, June 17, 2025 /PRNewswire/ -- Power Construction Corporation of China ("POWERCHINA" or "the Company") announced that the CEME1 photovoltaic project in Chile, the country's largest single-entity solar power facility, has now officially...
Results from Phase 1/2 Study of Kelun-Biotech's TROP2 ADC Sacituzumab Tirumotecan (sac-TMT) in Patients with Unresectable Locally Advanced or Metastatic Solid Tumors Refractory to Standard Therapies, Published in Journal of Hematology & Oncology
CHENGDU, China, June 10, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") today announced that results from the Phase 1/2 study (KL264-01/MK-2870-001) evaluating the novel TROP2 antibody drug conjugate (ADC)...
Asia Tech x Singapore 2025 Recap
SINGAPORE, June 10, 2025 /PRNewswire/ -- At the recent ATxSummit, the apex event of Asia Tech x Singapore (ATxSG) 2025, organised by the Infocomm Media Development Authority of Singapore (IMDA), key global and regional efforts around AI, LLM models,...
Heungkong, Panasonic and Tantron Unveil Breakthrough in Forest-Ecology-Inspired Indoor Bionic Technology
GUANGZHOU, China, June 10, 2025 /PRNewswire/ -- Heungkong Group, Panasonic Electric, and Tantron Technology have announced the mid-stage outcomes of their collaborative innovation, the "8 Constants+ Forest Environment System," on World Environment...
Planet Green Advances AI-Powered Early Mental Health Intervention for Youth in Post-Pandemic Canada
NEW YORK, June 9, 2025 /PRNewswire/ -- Planet Green Holdings Corp. ("Planet Green", the "Company") (NYSE American: PLAG) announced that its subsidiary Fast Approach Inc., ("Fast Approach"), a leader in applied AI technology, today announced a...
RayNeo Launches X3 Pro: Redefining AR with Cutting-Edge Tech
SHENZHEN, China, May 28, 2025 /PRNewswire/ -- RayNeo, a trailblazer in consumer AR technology, today unveiled its revolutionary product lineup at the "See the Extraordinary" launch event, marking China's ascendancy in the global XR arena. The...